What You Should Know:
- CoachCare, a leading remote patient monitoring (RPM) and virtual health company, has made its fourth acquisition in 12 months, snapping up Nashville-based Verustat for an undisclosed amount.
- This strategic move further strengthens CoachCare's position in the rapidly growing RPM market, projected to reach $175.2 billion by 2027.
Strengthening Focus on Chronic Conditions
Founded in 2020, Verustat brings valuable expertise in primary care and cardiology, areas
Read More
Healthcare M&A | M&A News, Analysis, Insights - HIT Consultant
TREND Health Acquires Advent for AI-Powered Healthcare Payment Accuracy
What You Should Know:
- TREND Health Partners, a rapidly growing provider of AI-driven solutions, has acquired Advent Health Partners, an AI-driven platform identifies and standardizes clinical attributes from itemized bills and medical records, expediting critical information presentation and ensuring timely and appropriate reimbursement.
- This strategic combination brings together two industry powerhouses, creating a comprehensive platform for payers and providers seeking to optimize
Read More
Lunit Acquires AI-Enabled Breast Cancer Detection Platform Volpara for $193M
What You Should Know:
- South Korean AI leader Lunit has announced its intention to acquire Volpara, a global pioneer in AI-powered cancer detection software, in a landmark deal worth AUD 292M (USD 193M).
- Beyond market presence, it's Volpara's deep knowledge and extensive data that truly sets it apart. With over 100 million high-quality mammogram images in its repository, Volpara offers a treasure trove of insights that will supercharge Lunit's AI capabilities and pave the way for
Read More
AstraZeneca Acquires Icosavax for $1.1B to Advance RSV and hMPV Vaccine Development
What You Should Know:
- AstraZeneca has announced the acquisition of Icosavax, a biopharmaceutical company developing a promising vaccine targeting both RSV and hMPV, for a total of up to $1.1 billion.
- This acquisition strengthens AstraZeneca's respiratory pipeline and aligns with their strategy of addressing high unmet needs in infectious diseases.
Building on Expertise in RSV Prevention
Icosavax's lead program, IVX-A12, is a Phase III-ready vaccine candidate targeting both
Read More
Cigna Ends Acquisition Talks with Humana, Announces $10B Share Repurchase Plan
What You Should Know:
- Health insurer Cigna has called off its attempt to acquire rival Humana after failing to reach an agreement on price, according to sources familiar with the matter, CNBC first reports.
- The talks, which were revealed in November 2023, would have created a combined company exceeding $140B in value, but faced significant antitrust scrutiny.
- The deal's failure comes six years after similar mega-mergers in the health insurance industry were blocked by regulators.
Read More
ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
What You Should Know:
- ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).
- This strategic move will significantly enhance and expand CancerLinQ's capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.
CancerLinQ Background
CancerLinQ represents one of the largest oncology
Read More
R1 RCM Acquires Acclara for $675M, Secures 10-Year RCM Partnership with Providence Health System
What You Should Know:
- R1 RCM Inc. (NASDAQ: RCM), a provider of technology-driven solutions for healthcare providers, announced a significant strategic partnership involving the acquisition of Acclara and a 10-year revenue cycle management agreement with Providence, one of the nation's largest health systems.
- The acquisition of Acclara for $675M in cash and warrants will bolster R1's offerings and position it as the "trusted partner of choice" in comprehensive revenue cycle management.
Read More
Fountain Life Acquires LifeOmic to Optimize Preventative Care
What You Should Know:
- Fountain Life, a leader in advanced diagnostics and preventative healthcare, has acquired LifeOmic, a health data technology company specializing in precision medicine.
- This acquisition significantly strengthens Fountain Life's ability to deliver data-driven, proactive healthcare services to its members.
Acquisition Optimizes Fountain Life’s Preventative Care Offerings
LifeOmic's technology platform will become the backbone of Fountain Life's offerings. The
Read More
PerkinElmer Acquires Covaris to Create Global Life-Sciences and Diagnostics Platform
What You Should Know:
- PerkinElmer, a leading global analytical services and solutions provider, announced its acquisition of Covaris, a developer of solutions for life science innovations.
- This strategic move will fuel Covaris' growth and expand PerkinElmer's life sciences portfolio into the high-growth diagnostics market. Notably, both companies share majority ownership under New Mountain Capital, making the integration potentially smoother. While financial details remain undisclosed,
Read More
M&A: Experian Acquires Wave HDC to Enhance Healthcare Coverage Identification and Automation
What You Should Know:
- Experian acquires Wave HDC, a healthcare technology leader that offers AI-enhanced data curation solutions to identify unknown insurance benefits coverage and critical patient demographics at the start of a patient's healthcare journey.
- The acquisition bolsters the Experian Health business portfolio with more comprehensive and faster healthcare coverage identification and automation capabilities.
Wave HDC's AI-Powered Solutions
Wave HDC offers several
Read More
